Stock Price
4.33
Daily Change
-0.51 -10.54%
Monthly
-26.98%
Yearly
-28.43%
Q1 Forecast
4.72

Silence Therapeutics reported $146.79M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AstraZeneca USD 114.46B 2.03B Sep/2025
Autolus Therapeutics Ltd USD 661.95M 59.03M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Silence Therapeutics USD 146.79M 18.44M Sep/2025